Business description: CohBar, Inc.

CohBar, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapeutics targeting chronic and age-related diseases. Its processes of identifying nucleic acid sequences encoding native peptides in the mitochondrial genome, developing and optimizing novel analogs of these natural mitochondrial derived peptides (MDPs) and developing and conducting screens to identify and characterize the activities of these are referred to as its technology platform. Its advanced clinical candidate, CB4211, is a therapeutic for the treatment of nonalcoholic steatohepatitis and obesity. CB4211 demonstrated positive effects on reducing biomarkers of liver injury and improving metabolic homeostasis in a Phase 1a/1b clinical study in obese subjects with nonalcoholic fatty liver disease. CB4211 is a novel and improved analog of MOTS-c, a naturally occurring MDP. CB5138 Analogs are therapeutics that have demonstrated anti-fibrotic properties in a variety of preclinical models.

Number of employees: 10

Sales by Activity: CohBar, Inc.

Fiscal Period: December20182019202020212022
See all business segments

Managers: CohBar, Inc.

Insider TitleAgeSince
Chief Tech/Sci/R&D Officer - 22-01-03
See COHBAR, INC. governance

Members of the board: CohBar, Inc.

Insider TitleAgeSince
Director/Board Member 63 Nov. 05
Composition of the Board of Directors

Shareholders: CohBar, Inc.

NameEquities%Valuation
182,074 6.263 % 91 037 $
RVW Wealth LLC
6.243 %
181,490 6.243 % 90 745 $
170,061 5.850 % 85 031 $
64,597 2.222 % 32 299 $
13,589 0.4675 % 6 795 $
List of COHBAR, INC. shareholders

Company details: CohBar, Inc.

CohBar, Inc.

1455 Adams Drive Suite 1308

94025, Menlo Park

+

http://www.cohbar.com
address CohBar, Inc.(CWBR)

Other Biotechnology & Medical Research

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-16.84%0.00%-93.31%-99.41% 581K
-2.52%-4.73%-3.92%-66.12% 45.3B
-0.02%+3.67%+4.64%-4.15% 43.52B
+0.23%+2.63%+7.64%-25.94% 42.73B
+0.93%-1.47%+22.96%+29.64% 29.91B
+2.22%+0.47%+31.21%-23.59% 28.86B
-0.14%-0.64%+36.74%+52.19% 27.43B
-1.53%+0.05%+34.94%+79.66% 14.71B
+1.44%-0.87%-11.72%-34.56% 12.23B
+0.97%-0.33%+7.31%-43.88% 11.46B
Average -1.53%+0.12%+3.65%-13.62% 25.61B
Weighted average by Cap. -0.04%+0.26%+13.28%-9.37%
See all sector performances